Counteraction of pRb-dependent protection after extreme hypoxia by elevated ribonucleotide reductase

Cell Proliferation

Volumn 37, Issue 5, 2004, Pages 367-383

  Graff, Pål ^a   Seim, J ^a   Amellem O ^b   Arakawa, H ^c   Nakamura, Y ^d   Andersson, K K ^a   Stokke, T ^e   Pettersen, E O ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Dynal Biotech ASA   (Norway)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; RETINOBLASTOMA PROTEIN; RIBONUCLEOTIDE REDUCTASE;

ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CELL DIVISION; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DEPHOSPHORYLATION; DNA REPLICATION; DNA SYNTHESIS; HUMAN; HUMAN CELL; HYPOXIA; PROTEIN BINDING; PROTEIN FUNCTION; REOXYGENATION;

CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DNA REPLICATION; HUMANS; ONCOGENES; OXYGEN; PROTEIN BINDING; RETINOBLASTOMA PROTEIN; RIBONUCLEOTIDE REDUCTASES; S PHASE; TUMOR STEM CELL ASSAY; UP-REGULATION;

EID: 4644318397     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2004.00319.x     Document Type: Article

References (37)

1. ÅMELLEM Ø, PETTERSEN EO (1991) Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage. Cell Prolif. 24, 127.
2. ÅMELLEM Ø, LÖFFLER M, PETTERSEN EO (1994) Regulation of cell proliferation under extreme and moderate hypoxia: the role of pyrimidine (deoxy) nucleotides. Br. J. Cancer 70, 857.
3. 2 phase during hypoxic stress. Exp. Cell Res. 227, 106.
4. ÅMELLEM Ø, STOKKE T, SANDVIK JA, KARLSEN F, PETTERSEN EO (1998) The retinoblastoma protein-associated cell cycle arrest in S-phase under moderate hypoxia is disrupted in cells expressing HPV18 E7 oncoprotein. Br. J. Cancer 77, 862.
5. ANDERSSON KK, GRÄSLUND A (1995) Diiron-oxygen proteins. In: Sykes AG, ed. Advanced Inorganic Chemistry, p. 353. Orlando: Academic Press.
6. BASERGA R (1999) The IGF-I receptor in cancer research. Exp. Cell Res. 253, 1.
7. BOAG JW (1970) Cell respiration as a function of oxygen tension. Int. J. Radiat. Biol. 18, 475.
8. EKLUND H, UHLIN U, FÄRNEGÅRDH M, LOGAN DT, NORDLUND P (2001) Structure and function of the radical enzyme ribonucleotide reductase. Prog. Biophys. Mol. Bio. 77, 177.
9. ENGSTRÖM Y, ERIKSSON S, JILDEVIK I, SKOG S, THELANDER L, TRIBUKAIT B (1985) Cell cycle-dependent expression of mammalian ribonucleotide reductase. J. Biol. Chem. 260, 9114.
10. FAN HZ, VILLEGAS C, HUANG AP, WRIGHT JA (1996) Suppression of malignancy by the 3′ untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs. Cancer Res. 56, 4366.
11. FAN H, VILLEGAS C, HUANG A, WRIGHT JA (1998) The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation. Cancer Res. 58, 1650.
12. FROESE G (1962) The respiration of ascites tumour cells at low oxygen concentrations. Biochim. Biophys. Acta 57, 509.
13. 2 by ionizing radiation. Int. J. Radiat. Biol. 79, 413.
14. GRAFF P, ÅMELLEM Ø, ANDERSSON KK, PETTERSEN EO (2002) Role of ribonucleotide reductase in regulation of cell cycle progression during and after exposure to moderate hypoxia. Anticancer Res. 22, 59.
15. GREEN SL, GIACCIA AJ (1998) Tumor hypoxia and the cell cycle: implications for malignant progression and response to therapy. Cancer J. Sci. Am. 4, 218.
16. KEYDAR I, CHEN L, KARBY S, WEISS FR, DELAREA J, RADU M, CHAITCIK S, BRENNER HJ (1979) Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer 15, 659.
17. KIM CY, TSAI MH, OSMANIAN C, GRAEBER TG, LEE JE, GIFFARD RG, DIPAOLO JA, PEEHL DM, GIACCIA AJ (1997) Selection of human cervical epitelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res. 57, 4200.
18. KNUDSEN KE, BOOTH D, NADERI S, SEVERCHRONEOS Z, FRIBOURG AF, HUNTON IC, FERAMISCO JR, WANG JYJ, KNUDSEN ES (2000) RB-dependent S-phase response to DNA damage. Mol. Cell Biol. 20, 7751.
19. KOLBERG M, STRAND KR, GRAFF P, ANDERSSON KK (2004) Structure, function, and mechanism of ribonucleotide reductases. BBA-Proteins Proteom. 1699: 1-34.
20. KORITZINSKY M, FURRE T, ÅMELLEM Ø, PETTERSEN EO (1998) Survival of synchronized human NHIK 3025 cells irradiated aerobically following a prolonged treatment with extremely hypoxic conditions. Int. J. Radiat. Biol. 74, 491.
21. LÖFFLER, M (1987) Restimulation of cell cycle progression by hypoxic tumour cells with deoxynucleosides requires ppm oxygen tension. Exp. Cell Res. 169, 255.
22. LØVHAUG D, WIBE E, OFTEBRO R, PETTERSEN EO, BRUSTAD T (1977) Recovery from X-ray induced damage in human cells grown in culture. Neoplasma (Bratislava) 24, 513.
23. NlCULESCU AB, CHEN XB, SMEETS M, HENGST L, PRIVES C, REED SI (1998) Effects of p21 (Cip1/Waf1) at both the G(1)/S and the G(2)/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell Biol. 18, 629.
24. OFTEBRO R, NORDBYE K (1969) Establishment of four new cell strains from human uterine cervix. Exp. Cell Res. 58, 459.
25. PETTERSEN EO, LINDMO T (1981) Low concentrations of misonidazole counteracts effects of extreme hypoxia on cells in S. Br. J. Cancer 43, 355.
26. PROBST H, SCHIFFER H, GEKELER V, KIENZLEPFEILSTICKER H, STROPP U, STOTZER KE, FRENZELSTOTZER I (1988) Oxygen dependent regulation of DNA-synthesis and growth of Ehrlich ascites tumor-cells in vitro and in vivo. Cancer Res. 48, 2053.
27. PROBST H, SCHIFFER H, GEKELER V, SCHEFFLER K (1989) Oxygen dependent regulation of mammalian ribonucleotide reductase in vivo and possible significance for replicon initiation. Biochem. Biophys. Res. Com. 163, 334.
28. PROBST G, RIEDINGER HJ, MARTIN P, ENGELCKE M, PROBST H (1999) Fast control of DNA replication in response to hypoxia and to inhibited protein synthesis in CCRF-CEM and HeLa cells. Biol. Chem. 380, 1371.
29. ROFSTAD EK (2000) Microenvironment-induced cancer metastasis. Int. J. Radiat. Biol. 76, 589.
30. SJOBERG BM (1997) Ribonucleotide reductases - a group of enzymes with different metallosites and a similar reaction mechanism. Structure Bonding 88, 139.
31. STOKKE T, ERIKSTEIN BK, SMEDSHAMMER L, BOYE E, STEEN HB (1993) The retinoblastoma gene-product is bound in the nucleus in early G1-phase. Exp. Cell Res. 204, 147.
32. STOKKE T, SMEDSHAMMER L, JONASSEN TS, BLOMHOFF HK, SKARSTAD K, STEEN HB (1997) Uncoupling of the order of the S and M phases: effects of staurosporine on human cell cycle kinases. Cell Prolif. 30, 197.
33. TANAKA H, ARAKAWA H, YAMAGUCHI T, SHIRAISHI K, FUKUDA S, MATSUI K, TAKEI Y, NAKAMURA Y (2000) A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404, 42.
34. THELANDER L, GRÄSLUND A (1993) Ribonucleotide reductase in mammalian systems. In: Sigel H, Sigel A, eds. Metal Ions in Biological Systems, p. 109. Basel: Marcel Dekker Inc.
35. THELANDER L, GRASLUND A, THELANDER M (1983) Continual presence of oxygen and iron required for mammalian ribonucleotide reduction - possible regulation mechanism. Biochem. Bioph. Res. Co. 110, 859.
36. WOUTERS BG, KORITZINSKY M, CHIU RK, THEYS J, BUIJSEN J, LAMBIN P (2003) Modulation of cell death in the tumor microenvironment. Semin. Radiat. Oncol. 13, 31.
37. YOUNG SD, MARSHALL RS, HILL RP (1988) Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor-cells. Proc. Natl Acad. Sci. USA 85, 9533.